首页> 外文期刊>The Quarterly Journal of Nuclear Medicine >Angiogenic and angiostatic factors in the molecular control of angiogenesis.
【24h】

Angiogenic and angiostatic factors in the molecular control of angiogenesis.

机译:血管生成的分子控制中的血管生成和血管抑制因子。

获取原文
获取原文并翻译 | 示例
           

摘要

The vascular system that ensures an adequate blood flow is required to provide the cells with sufficient supply of nutrients and oxygen. Two different mechanisms of the formation of new vessels can be distinguished: vasculogenesis, the formation of the first primitive vascular plexus de novo and angiogenesis, the formation of new vessels from preexisting ones. Both processes are regulated by a delicate balance of pro- and anti-angiogenic factors. Physiologically, angiostatic mediators outweigh the angiogenic molecules and angiogenesis does not occur. Under certain conditions such as tumor formation or wound healing, the positive regulators of angiogenesis predominate and the endothelium becomes activated. Angiogenesis is initiated by vasodilatation and an increased permeability. After destabilization of the vessel wall, endothelial cells proliferate, migrate and form a tube, which is finally stabilized by pericytes and smooth muscle cells. Numerous soluble growth factors and inhibitors, cytokines and proteases as well as extracellular matrix proteins and adhesion molecules strictly control this multi-step process. The properties and interactions of angiogenic molecules such as VEGFs, FGFs, angiopoietins, PDGF, angiogenin, angiotropin, HGF, CXC chemokines with ELR motif, PECAM-1, integrins and VE-cadherin as well as angiostatic key players such as angiostatin, endostatin, thrombospondin, CXC chemokines without ELR motif, PEDF are discussed in this review with respect to their molecular impact on angiogenesis.
机译:需要确保足够的血流的血管系统来为细胞提供足够的营养和氧气供应。可以区分出形成新血管的两种不同机制:脉管形成,第一原始血管新生的形成和血管生成,由先前存在的新血管的形成。两种过程均受促血管生成因子和抗血管生成因子的微妙平衡调节。从生理学上讲,血管抑制介质的作用超过了血管生成分子,并且不会发生血管生成。在某些情况下,例如肿瘤形成或伤口愈合,血管生成的正调节剂占主导,内皮被激活。血管生成是由血管扩张和通透性增加引起的。血管壁不稳定后,内皮细胞增殖,迁移并形成管子,最后被周细胞和平滑肌细胞稳定。许多可溶性生长因子和抑制剂,细胞因子和蛋白酶以及细胞外基质蛋白和粘附分子严格控制了这一多步过程。血管生成分子(如VEGF,FGF,血管生成素,PDGF,血管生成素,血管生成素,HGF,具有ELR基序的PEK-1,整合素和VE-钙粘着蛋白的CXC趋化因子以及血管生成抑制因子(如血管抑制素,内皮抑素,在本综述中讨论了血小板反应蛋白,无ELR基序的CXC趋化因子,PEDF对分子对血管生成的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号